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Abstract A study was conducted to investigate the effect of
interleukin-1β (IL-1β) on hypoxia ischemia (HI) of cultured
astrocyte and neonatal rat models and to explore the underly-
ing molecular regulation mechanism. Primary rat astrocyte
was exposed to hypoxia (2 % O2, 98 % N2) and cultured in
serum-free medium for 6, 12, and 18 h to establish cell model
of HI. Morphologic changes of astrocyte were monitored and
gene expression change of IL-1β evaluated by real-time po-
lymerase chain reaction (PCR). To establish the HI animal
model, 3 days old postnatal Sprague–Dawley (SD) rats were
treated with the right carotid artery ligation and were exposed
to 8 % oxygen for 8, 16 and 24 h, respectively. Longa score
scale, hematoxylin and eosin (HE) staining and water content
were examined to assess neurologic function and morphology
changes. IL-1β siRNA lentivirus (IL-1β-RNAi-LV) was
injected into cerebral cortex motor area 2 days before HI and
the interference efficiency examined by real-time PCR and
Western blotting, respectively. Immunofluorescence staining
of GFAP and IL-1β was performed to identify the location
and interference effect of IL-1β, respectively. To further ex-
plore the potential mechanisms, the expression of inflamma-
tory factors, including IL-6, IL-10 and tumor necrosis factor-
alpha (TNF-α), was examined following IL-1β down-
regulation. The size of soma astrocyte was increased greatly
after 12 and 18 h of HI with IL-1β up-regulation. IL-1β
knockdown by siRNA in vitro or by lentivirus in vivo can
reverse cell swelling, brain edema and neurologic function
deficiencies induced by HI. Lastly, interference of IL-1β
remarkably increased IL-6 expression but not IL-10 and
TNF-α. Therefore, down-regulation of IL-1β improves the
deficiencies of neurologic function and morphology induced
by HI, maybe closely associating with IL-6 regulation.
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Introduction
Hypoxia–ischemia (HI) insult of neonatal is a vital cause of
perinatal brain injury, which may cause cerebral palsy, sei-
zures, learning limitations and epilepsy [1–4]. The incidence
of neonatal HI increases risk of mortality and lifelong mor-
bidity in newborns, and reaches 2–6‰ live term births each
year inWestern countries [5, 6]. Currently, there is no effective
therapy that could minimize brain disorder induced by HI
in clinical. The treatment strategies are restricted due to the
lack of knowledge regarding the related neuronal networks
and the underlyingmechanisms of neurodegeneration induced
by HI.
Inflammation, as a complex intrinsic network of multiple
subsets of immune cells, plays a pivotal role in HI pathogen-
esis. The phenomenon of apoptotic, swelling, necrotic cell
deaths and excitotoxicity is prominent in the developing brain
edema after HI [7–10]. However, inflammation is a protective
response of the organism to remove the injurious events and to
initiate the healing process. Interleukin-1β (IL-1β), a member
of the interleukin 1 cytokine family that was produced by
activated macrophages as a proprotein, is known to play a
major role in the development of osteoarthritis, hypoxic is-
chemic encephalopathy and hepatic damage [11–13].
However, the exact role of IL-1β in brain edema with HI
remains elusive. Recent studies have shown that inhibition of
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IL-1 expression by IL-1 receptor antagonist could atten-
uate dysfunction following HI [14]. IL-1β, interleukin-6
(IL-6) and tumor necrosis factor-alpha (TNF-α) in cere-
brospinal fluid (CSF) were correlated with the severity
of brain injury and can serve as the diagnosis indicators
in infants who suffered from HI [12]. Additionally,
intracerebral injection of IL-1β in adult mice activated
nuclear factor-kappaB (NF-κB) signaling pathway and
induced leukocytes infiltration into the brain tissue [15].
Although there is clear evidence that IL-1β plays a
crucial role in HI, there is no sufficient evidence to
identity the cause-and-effect relationship and potential
regulation mechanism. We therefore studied the role of
IL-1β in the HI astrocyte cell model and neonatal
animal model to determine the underlying molecular
mechanism.
Methods
Primary Culture of Astrocytes and HI Cell Model
For isolation of rat cerebral astrocytes, 3 days old neonatal rat
pups were provided by Sichuan University according to Insti-
tutional Animal Care and Use Committee guidelines. They
were deeply anesthetized by diethylether and euthanized by
decapitation. Leaving behind the white matter, the cortex
tissue was gently separated, and the meninges were gently
peeled. Cortices were cutting into small pieces, dissociated
into a cell suspension and plated in 75-cm2 tissue culture
flasks (Corning). Tissue with modified DMEM/F12 culture
media at a concentration of 1.5×106 cells/ml was incubated in
standard humidified 5 % CO2 at 37 °C for 72 h. Cells were
maintained by feeding every 3 days with the fresh medium.
After culturing cells for 7–9 days, flasks were shaken at
350 rpm for 6 h at 37 °C to separate the oligodendrocytes
from the astrocytes. Those shaken flasks were exchanged with
10 ml of fresh medium and the shaking procedure was repeat-
ed for an additional 18 h to harvest purified astrocytes. The
purity of astrocyte was evaluated with staining with glial
fibrillary acidic protein (GFAP). Then cells were exposed to
hypoxia (2 % O2, 98 % N2) and cultured in serum-free
medium for 6, 12 and 18 h to establish cell model of HI.
Morphologic changes of astrocyte following HI was observed
under a phase contrast microscopy.
Quantitative RT-PCR
Total RNA was extracted from primary rat astrocytes using
Trizol reagent (Invitrogen) and reversed transcribed to
cDNA with the RevertAid™ First Strand cDNASynthesis
kit (Invitrogen) according to the manufacturer’s protocol.
QRT-PCR for five genes was then performed to examine the
expression of mRNA. The primer sequences were listed as
follows: IL-1β: forward, 5′-GAGCTGAAAGCTCTCCAC




CTTT-3′; TNF-α: 5′-GCCCACGTCGTAGCAA-3′; reverse,
5′-GTCTTTGAGATCCATGCCAT-3′; β-actin: 5′-GAAGAT
CAAGATCATTGCTCCT-3′; reverse, 5′-TACTCCTGCTTG
CTGATCCA-3′; Gene expression quantitation was carried out
in a DNA thermal cycler (ABI 7300) according to the follow-
ing standard protocol: a denaturation step of 95 °C for 2 min;
40 cycles of 95 °C for 15 s, annealing for 20 s, and annealing
temperature at 60 °C for 40 s. The housekeeping gene β-actin
was used as an endogenous control to normalize mRNA
content for each sample, and non-template control was as
negative controls for samples of multiple wells. The mRNA
level was relatively quantified by using the 2−△△Ct method.
IL1-β siRNA
Not-targeting and targeting siRNAwere obtained from Ruibo
Company Guangzhou, China. Three 19-nucleotide sequences
were designed corresponding to the IL-1β reference sequence
(NCBI, NM_031512.2) to specific silencing of IL-1β. The
sequence of those fragments was as follows: F1, CCAAGT
CCGTCTTCTACAT; F2, CAGGTGCACTTTACGAGTA;
F3, CAGCATGAATCCAGCTCGA. Non-targeting siRNA
was constructed using a 19-nucleotide sequence which is no
homology to any mammalian gene sequence as negative
control.
siRNATransfection
To select the one with maximum interference efficiency of
fragments of IL-1βsiRNAvector and the most optimized time
point of transfection, cerebral astrocytes were transfected by
three candidate target fragments of IL-1βsiRNA. There were
four groups in this experiment as following: normal group,
tansfection reagent group, negative control group and IL-
1βsiRNA group. Cells were incubated with transfection mix
(4 μl IL-1βsiRNA, 3 μl transfection reagent and 100 μl
transfection buffer) for 2, 4 and 7 days according to the
manufacturer’s instructions, respectively. The inhibition rate
of three fragments and the best time point of transfection were
validated by a quantitative real-time RT-PCR as described
above.
Then the siRNA of highest inhibition rate was transfected
into astrocytes of HI to explore the function of IL-1β. And the
morphologic changes of astrocyte after IL-1βsiRNA treat-
ment was observed and collected by a phase contrast micros-
copy. Non-targeting siRNAwas transfected into astrocytes as
negative control.
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IL-1β siRNA Lentivirus
The sequence information of the highest inhibition rate of IL-
1βsiRNA was provided to GeneCopoeia Company (Guang-
Zhou, China) to construct IL-1β siRNA expression vector.
Briefly, IL-1β siRNA lentivirus ((IL-1β-RNAi-LV)) was pro-
duced by co-transfected IL-1β expression vector and viral
packaging system (gag, pol and env) into 293 T cells accord-
ing to the manufacturer’s protocol. Forty-eight hours after
transfection, virus medium was harvested, filtered through a
0.45-mm cellulose acetate filter, purified and concentrated by
concentration solution (GeneCopoeia Company). Finally, the
IL-1β-RNAi-LV was frozen at -80 °C for following
experiment.
HI Rat Model and IL-1β-RNAi-LV Injection
Three-day-old SD rat pups (weighing 8–9 g), provided by the
Animal Experimental Center of Sichuan University, were
employed in this study. All animal procedures used were
approved by University Committee on Animal Use and Care.
Rat pups were randomly divided into four groups showed in
Table 1. Briefly, the pups were kept under inhalation diethyl
ether anesthesia during the entire procedure, and temperature
of scalp and body was maintained at 37 °C by a
homoisothermy bench. Following 0.5 cm skin incision in the
midline of the neck, and the right common carotid artery
(CCA) was permanently ligatured with 5–0 silk. Following
surgery, rats were returned to their mother for recovery and
feeding for 30 min. Then the pups were taken into an airtight
chambermaintaining the ambient temperature inside the cham-
ber at a constant 37 °C for hypoxia (8 %O2, 92 %N2) for 8, 16
and 24 h, respectively. The sham group only underwent a neck
dissection and put the silk around carotid artery, but not
ligated; the pups in HI group only occlude the CCA; IL-
1β-RNAi-LV (4μl) was injected into cerebral cortex motor area
of right hemisphere in IL-1β-RNAi-LV group and no-targeting
lentivirus injection was used as a negative control group.
Behavioral Analyses
The blinded Longa scale score test for neural impairment was
performed before surgery and at different time points (8, 16
and 24 h) after HI surgery. There were five scales in this test as
following. A score of 0 indicates no neurologic deficit; a score
of 1 failing to extend left forepaw fully, indicating a mild focal
neurologic deficit; a score of 2 circling to the left, indicating a
moderate focal neurologic deficit; a score of 3 indicates a
severe focal deficit with falling to the left; a score of 4 indicates
a depressed level of consciousness and failure to walk
spontaneously.
Brain Water Content
For sham and HI groups, the brains of rat pups (n=6) were
used to measure the water content. The wet weight was
measured first, and then the dry weight of tissue was measured
after the tissue dried at 100 °C for 24 h. Brain water content
was caculated by next forum: (as a percentage)=(wet weight−
dry weight)/wet weight×100 %.
Hematoxylin and Eosin Staining
After anesthesia, rat pups were perfused through the ascend-
ing aorta with 5 ml of 0.1 mol/l phosphate-buffered saline
(PBS; pH 7.2–7.3, room temperature), followed by 5 ml of
4 % paraformaldehyde in PBS. Tissues were paraffin-
embedded after dehydration, serial horizontal sections
(4 μm thickness) were stained with hematoxylin and
eosin (HE) to examine the morphology changes of brain.
Microscopic image was acquired by Leica AF6000
microscope.
Immunofluorescence Staining
To examine the changes of astrocyte swelling, the location and
expression of IL-1β following IL-1β-RNAi-LV injection, com-
parative analysis of immunofluorescence staining was per-
formed in the brain tissue section. Briefly, the brain was removed
and postfixed in 4% paraformaldehyde solution for 24 h follow-
ed by gradient of dehydration in 10 %, 20 %, 30 % of sugar
solution for 24 h successively. Tissues were OCT-embedded
after dehydration, and cut vertically through injection point with
10 μm thickness by freezing microtome (Leica CM1900;
Wetzlar, Hesse, Germany). The sections were incubated with
rabbit anti-GFAP antibody (1:100; Zhongshan Jinqiao, China)
Table 1 Animal grouping
Animal grouping 8 h 16 h 24 h
Sham group (Sham) n=12 n=12 n =12
Hypoxia ischemia group (HI) n=12 n=12 n =12
Hypoxia ischemia with no-targeting lentivirus (Negative Control) n=12 n=12 n =12
Hypoxia ischemia with IL-1β-targeting lentivirus (IL-1β-RNAi-LV ) n=12 n=12 n =12
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together with mouse anti-IL-1β antibody (1:100; Abcam, Cam-
bridge, MA, USA) at 4 °C overnight, and then followed
by fluorescence secondary antibodies, including CY3 anti-
rabbit IgG (red), Alexa Fluor 488 anti-mouse IgG (green)
and Alexa Fluor 488 anti-rabbit IgG (green). Control experi-
ments were carried out by replacing the primary antibodies
with normal serum. Section image was collected using a
confocal microscope (Zeiss LSM).
Western Blotting Analysis
To examine whether the protein expression of IL-1β was
reduced after IL-1β-RNAi-LV injection, brain samples were
removed and protein extracted for western blotting experi-
ment. Protein (80 μg) was separated by SDS-PAGE. After
electrophoresis for 120 min at 75 V, the proteins were trans-
ferred to PVDF membranes (Millipore, Billerica, MA, USA).
The membranes were then blocked in 5 % nonfat milk in
PBST for 120 min at room temperature and incubated with
primary antibody of IL-1β (Abcam), diluted 1:1,000 in 5 %
BSA overnight at 4 °C. After incubation with the primary
antibody, the membranes were washed in three changes of
PBST and incubated for 2 h with secondary antibody (goat
anti-rabbit IgG; ZSGB-BIO, China) diluted at 1:5,000. Final-
ly, membranes were repeatedly rinsed in TBST three times
and the immune complexes were revealed using Alpha
Innotech (Bio-Rad) with ECL.
Statistical Analysis
The statistical significance between groups was determined on
the basis of one-way analysis of variance test (ANOVA) with
SPSS17.0. Statistical significance was defined at P<0.05. All
data are expressed as mean±SEM.
Results
Astrocytes Swelling and Inflammatory Factors Up-regulation
Following HI
After purification of primary culture of cerebral astrocyte by
mechanical shaking, GFAP, a specific maker of astrocyte, was
used to stain for identification of the astrocyte. The result
showed GFAP expressed in cytoplasm and emitted green
fluorescence surrounding the blue nuclein (Fig. 1a). Those
GFAP-positive cells were identified as astrocytes.
The images of astrocyte following HI were collected by a
phase contrast microscopy. Compared with normoxia group,
the size soma of astrocyte was significantly increased starting
at 12 h after HI, suggesting that cell swelling was induced by
HI (Fig. 1b,c). However, the number of astrocytes was
significantly decreased in HI12h and HI18h (P<0.05 vs.
control; Fig. 1b,d), while there was no significant difference
between the 6 h HI and normoxia groups. Therefore, 12 h of
HI was used in the following studies (Fig. 1b–d).
PCR results showed the mRNA of IL-1β was significantly
increased after HI treatment for 12 and 18 h when compared
with that in normoxia group (Fig. 1e).
The Most Effective siRNA Fragment and the Optimal Time
Point of Transfection Selection
Three IL-1β-specific siRNA fragments (F1, F2, F3) were
transfected into astrocyte for 2 days, and the silencing effect
was examined by real-time PCR. Internalization into no-
targeting fragment, the expression ratios of F1, F2 and F3
were 0.435, 0.330 and 0.308, respectively. Therefore, F3 has
the maximum interference efficiency and was used in the
following studies (Fig. 2a).
To explore the optimal siRNA-dependent silencing effect
of IL-1β at 2, 4 and 7 days after transfection of F3, the
mRNA levels were determined by real-time PCR, as de-
scribed in Methods. Compared with the non-targeting se-
quence, IL-1β expression was most significantly inhibited
after 2 days transfection (Fig. 2b–d). Therefore, F3 of IL-
1βsiRNA and 2 days post transfection time point were
used in the following studies.
Effect of IL-1β siRNA on Astrocyte Morphology In Vitro
To explore the function of IL-1β, F3 of IL-1βsiRNA was
transfected into astrocytes of HI for 2 days and the astrocyte
morphologic changes were observed and collected by a phase
contrast microscopy. Non-targeting siRNA was transfected
into astrocytes as negative control. The size of soma of astro-
cyte showed marked decrease in IL-1βsiRNA injection group
(P<0.05 vs. HI12h) (Fig. 2e,f). These findings suggested that
IL-1βsiRNA treatment can reverse swelling of astrocyte in-
duced by HI.
Functional andMorphological Consequence Induced by HI In
Vivo
Neural function following HI was assessed by Longa Score
Scale, which was performed 8, 16 and 24 h after hypoxia (8 %
O2, 92 % N2) until sacrifice. Statistic analysis showed that
under HI intervention, Longa Score in the in HI groups (8, 16
and 24 h) was significantly increased compared with that of
the control. Moreover, this score was gradually increased in a
time-dependent manner with a statistically difference
among different time points of HI groups (Fig. 3a). Water
quantity of brain tissue started to dramatically increase after
8 h and gradually increased with time of HI treatment. How-
ever, there was no significant difference among HI groups
746 Mol Neurobiol (2015) 51:743–752
(Fig. 3b). To investigate the effects of HI on brain edema,
morphology changes were examined by HE staining. The
result showed the ultrastructural changes of cells, and swelling
cells with abnormally circular and enlarged space around cells
were presented in HI group; while no abnormal signs were in
normoxia group. Furthermore, basophil cell was more in HI
group than that of in control group. Those results confirmed
that brain edema with inflammation could be induced by HI
(Fig. 3c).
Effect of HI Event on Astrocyte Morphology In Vivo
Immunofluorence staining of GFAP was performed to deter-
mine the effect of HI on the morphology of astrocytes. The
swelling GFAP positive cells were observed in HI group and
the size of soma of GFAP positive cells was greatly increased
(P<0.01) when compared with that in the control group
(Fig. 4), suggesting that astrocyte swelling was induced by
HI administration.
IL-1β mRNA and Protein Expression Change Following HI
The effect of HI on the level of IL-1β mRNA and protein
was measured by real-time PCR and Western Blotting
analysis, respectively. IL-1β gene expression in brain tis-
sue was increased remarkably in HI-treatment rats com-
pared with that of rats maintained on the normoxia
(Fig. 5a). As predicted, IL-1β protein expression
showed a consistent pattern as mRNA levels detected
by real-time PCR during HI treatment (Fig. 5b,c).
Effect of Lentivirus Injection into Brain Tissue on IL-1β
After IL-1β-RNAi-LV injection into rats’ cortex, the
protein expression of IL-1β was significantly reduced
in IL-1β-RNAi-LV group (P < 0.01 vs. control;
Fig. 6a,b). Moreover, immunofluorescent staining analy-
sis of control and IL-1β-RNAi-LV groups showed IL-
1β expression was down-regulated in IL-1β-RNAi-LV
group (Fig. 6d,e). Those findings confirmed the fact that
lentivirus recombinant of IL-1β undoubtedly silenced
the protein expression.
Astrocyte Swelling Ameliorated Following Lentivirus
Injection and Co-localization of GFAP and IL-1β
After IL-1β-RNAi-LV injection into the rats’ cortex,
immunofluorescent staining results showed the size of
soma of GFAP positive cells (red) was diminished when
compared with that one of control (Fig. 6d,e). More-
over, we found IL-1β+ cells (green) also expressed
GFAP (red), suggesting IL-1β and GFAP were co-
localized in astrocytes. Those results suggested astro-
cytes swelling resulted from HI was ameliorated after
Fig. 1 Effect of HI on astrocyte and IL-1β expression in vitro. The
astrocytes could be identified by cytoplasmic localization of GFAP
(green) immunofluorescent staining (a). Morphologic analysis showed
HI can cause cell swelling, and the size of soma was significantly
increased starting at 12 h after HI when compared with the control (b,
c). Moreover, the number of cells was significantly reduced at 12 and 18 h
after HI (b, d). Gene expression quantification showed IL-1β was sig-
nificantly increased after HI when compared with that of normoxia group
(e). Bar=20 μm, shown in a. *P<0.05, #P<0.01, compared with control
group
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interference of IL-1β expression in brain tissue by len-
tivirus injection.
Brain Edema Caused by HI Was Attenuated by IL-1β
Interference
To examine the effect of IL-1β interference on brain edema
caused by HI, HE staining was performed to assess the mor-
phology changes of the brain tissue. Compared with control
group, IL-1β interference reduced brain defects induced by
HI, including swelling or necrosis and illegible borders of cell
(Fig. 6c).
IL-1β Regulates Inflammation Factors Expression
To further explore the downstream signalingmolecules of IL1-β
and underlying mechanisms of IL-1β interference induced ben-
eficial effect on HI, real-time PCR was performed to examine
the changes of IL-6, IL-10 and TNF-α expression after IL-1β
interference. Compared with negative control group, the mRNA
expression of IL-6 was significantly increased (P=0.000;
Fig. 7a), while no significant effect on IL-10 and TNF-α gene
expressions. Consistent with the mRNA expression change,
the protein expression of IL-6 also showed increase after IL-
1β down-regulation (Fig. 7b).
Discussion
This study demonstrated that neurologic deficit, brain edema
and astrocyte swelling were caused by HI, which was accom-
panied by IL-1β up-regulation. However, this pathological
phenomenon was reversed and attenuated after IL-1β down-
regulation by siRNA in vitro and lentivirus in vivo. And our
findings suggested that IL-6 may be the downstream signaling
molecule of the IL-1β and associated with regulation of HI.
In the present study, the primary culture astrocyte
was administrated free-serum medium and exposed
2 % O2 and 98 % N2 for 6, 12 and 18 h to establish
Fig. 2 Cell swelling induced by HI was significantly attenuated at 2 days
of transfection by F3 of IL-1βsiRNA. Inhibition rate of F3 was around
69% compared to control one, while F1 and F2 that had an inhibition rate
around 56 % and 67 % by real-time PCR analyses (a). After F3 transfec-
tion into primary astrocyte at 2 days (b), 4 days (c) and 7 days (d), real-
time PCR analysis demonstrated the gene expression decreased
significantly at 2 days after transfection, and no significance decrease
was observed after 4 and 7 days (b–d). IL-1β down-regulation can
significantly attenuate cell swelling induced by HI at 2 days transfection
IL-1βsiRNA, compared with non-targeting siRNA (e). The quantifica-
tion of the size of soma astrocyte is shown at f. Bar=50 μm, shown in e.
Statistical significance, *P<0.05 and #P<0.01
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Fig. 3 Changes of function and morphology induced by HI. a Longa
score scale of sham group and HI group. Compared with sham group, HI
can cause significant deficiencies at 8, 16 and 24 h (n=12, *P<0.05).
Moreover, grading of severity of brain function was increased depending
on time after HI (#P<0.05). bBrain tissue’s water quantity of sham group
and HI group. Statistic analysis demonstrated that the water quantity of
brain in HI rats exhibited a significant increase, compared with sham one.
In addition, there was no significant difference between different time
points of HI. c HE staining of sham group and HI group (×400; 8, 16 and
24 h). Morphologic result showed cells swelling and abnormally circular
caused by HI in a time-dependent manner. Five fields were detected in
each case. The arrows show the swelling cells and the polygons show the
effusion of erythrocytes. Statistical significance, *P<0.05 and #P<0.01
Fig. 4 Effect of HI on astrocyte
morphology in vivo.
Immunofluorescent staining
result showed that the size of
soma of astrocyte was
significantly increased following
HI when compared with that in
sham group. DAPI staining is
presented in a and d. GFAP
staining is presented in b and e.
Merged image is presented in c
and f. Quantitative analysis of
soma is shown in g (n=5,
*P<0.05). Bar=50 μm, shown in
d
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cell model of HI. Three days postnatal rats were sub-
jected the right carotid artery ligation and subsequently
exposed to 8 % oxygen for 8, 16 and 24 h, respectively,
to establish animal model of HI. We examined the
variation of morphological and functional of astrocyte
and brain tissue following HI, and cellular swelling,
inflammatory cell infiltration and cellular necrosis were
observed and margin of cells was not clear in HI group;
the degree of neural dysfunction was present in time-
dependent manner under HI intervention; the water
quantity of brain tissue also gradually increased with
the extent of time of HI. Given that those changes
had a statistical significance when compared with their
control group, we reasoned that an HI model was suc-
cessfully established.
In this study, IL-1β was increased significantly in mRNA
level by real-time PCR following HI administration. The
results of recent studies were confirmed by our study. For
instance, up-regulation of IL-1β, ROS, and IL-8 by hypoxia/
ischemia occurred in human chondrocytes [11], similar to the
finding inHI of newborn rats that demonstrated the expression
of proinflammatory cytokines (TNF-α, IL-1β, IL-10) was
increased prominently 3 h after HI compared to mRNA levels
in sham-operated animals [13]. Conversely, Savman et al. [16]
suggested IL-1β had no relationship with the consequence of
HI, but was only observed in the most severe cases of infants
who eventually die or develop serious disabilities. This may
be due to the different target tissue examined. Difference from
vasogenic brain edema, cytotoxic brain edema induced-HI has
intact blood–brain barrier (BBB) [17]. Such an interesting
discrepant finding may indicate that the source of increased
IL-1β in the brain tissue is due to local cellular production of
central nervous system as opposed to overflowing from serum
via BBB. This explains why IL-1β in the serum is not correlated
with the outcomes of HI in infants in other studies.
To explore the role of IL-1β in HI encephalopathy, we
designed siRNA and constructed the lentevirus vector of IL-
1β shRNA to interfere its expression. The maximum interfer-
ence rate of siRNA fragment and the optimization time point
of transfection were selected in vitro. Considering IL-1β was
richly expressed in astrocytes suffered from HI, which was
supported by the result of fluorescence double-labeling of
GFAP and IL-1β, astrocyte was cultured as a good target cell
for transfection. Compared to negative controls, F3 of siRNA-
IL-1β had the maximum interference efficiency, and 2 days of
transfection was the optimization time point. Based on those
findings, we employed F3 (CTGCAGGCTTCGAGATGAA)
for the following construction lentevirus experiments.
After microinjection the lentivirus in the cortex motor area
of HI rat, Western blot and immunofluorescent staining results
showed IL-1β protein level was down-regulated significantly
in IL-1β-RNAi-LV group when compared with that in control
group. Moreover, the brain edema, swelling astrocyte and
neurologic deficit following HI were attenuated with down-
regulation IL-1β. Consistent with our findings, several studies
have also shown that there was a beneficial neuroprotective
role during down-regulation of IL-1, including inhibition of
microglial activation, neutrophil infiltration, and cytokine
levels. IL-1 receptor antagonist (IL-1ra), a naturally occurring
protein, binds to IL-1 receptors and blocks several actions of
IL-1. IL-1ra in the brain was reported as an endogenous
neuroprotective molecule in 1997 [18]. The volume of brain
infarct and disruption of BBB in ischemic brain of rat were
significantly reduced after administration of IL-1ra [19]. Sim-
ilarly, IL-1ra was used for patients with subarachnoid
Fig. 5 Changes of IL-1β expression following HI treatment. The mRNA
expression of IL-1β is shown in a. Although no changes between
different time points of HI groups were observed, there was a significant
increase in the level of mRNA of IL-1β with 8, 16 and 24 h HI treatment
(P<0.05 vs. Sham). The protein expression of IL-1β is shown in b and c.
Similar to the results of IL-1β mRNA expression, the expression of
protein for IL-1β was significantly increased at 8 and 16 h after HI
treatment when compared with the control (P<0.05)
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hemorrhage (SAH) to reduce brain injury induced by
focal cerebral ischemia in clinical therapy [20]. Upon analysis,
we blocked the actions of IL-1β by injection IL-1β-RNAi-LV
in our study, similar with the administration of IL-1ra.
Fig. 6 Effect of IL-1β-RNAi-LV injection into brain tissue. IL-1β pro-
tein was successfully silenced by lentivirus recombinant as shown byWB
(a, b). Results of HE staining demonstrated IL-1β down-regulation by
lentivirus can partially reverse brain edema induced by HI, when com-
pared with negative control group. And swelling or necrosis and illegible
borders of cell were ameliorated in the IL-1β-RNAi-LV group (c). d, e
Co-localization of GFAP (red) and IL-1β (green) in astrocytes. The green
fluorescence was significantly reduced in IL-1β-RNAi-LV group when
compared with its control group, suggesting the level of IL-1β protein
was successfully down-regulated by lentivirus. Moreover, the swelling of
astrocytes induced by HI were partly reversed by IL-1β-RNAi-LV trans-
fection. Bar=50 μm, shown in e. #Statistical significance of P<0.01
Fig. 7 Inflammation factors expression regulation by IL-1β. Compared
with negative control, although no statistically significant difference was
observed of IL-10 and TNF-α expression, IL-6 gene expression was
significantly increased after down-regulation of IL-1β (a). And IL-1β
protein expression was also significantly increased after HI treatment
when compared with the control (b). #Statistical significance of P<0.01
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Further study was performed to explore the molecular
mechanism of beneficial effects of down-regulation of IL-1β
on HI. We the ex found that IL-6 was significantly increased
when IL-1β expression was reduced.
These findings suggest that IL-1β may be a target gene
therapy of HI brain edema in neonates. The method of down-
regulation of IL-1β by RNA interference during HI may
protect against drain edema, stoke and other brain disorders
via up-regulation of IL-6 expression.
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